hydralazine and labetalol

hydralazine has been researched along with labetalol in 109 studies

Research

Studies (109)

TimeframeStudies, this research(%)All Research%
pre-199036 (33.03)18.7374
1990's14 (12.84)18.2507
2000's14 (12.84)29.6817
2010's33 (30.28)24.3611
2020's12 (11.01)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Lombardo, F; Obach, RS; Waters, NJ1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Gifford, RW; Tarazi, RC; Wollam, GL1
Craswell, PW; De Voss, K; Williams, JG1
Havard, CW; Pearson, RM1
Barnett, AJ; Guest, C; Kalowski, S1
Allonen, H; Kleimola, T; Lehtonen, A1
Boakes, AJ; Joekes, AM; Prichard, BN; Thompson, FO1
Barratt, TM; Deal, JE; Dillon, MJ1
Bunchman, TE; Lynch, RE; Wood, EG1
Stumpf, JL1
Fairlie, FM; Walker, JJ1
Ram, CV2
Allen, J; Forman, A; Maigaard, S; Skajaa, K1
Harper, A; Murnaghan, GA1
Imai, S; Nakahara, H; Nakazawa, M; Takeda, K1
Dimich, I; Gabrielson, G; Kaplan, JA; Lingham, R; Singh, PP1
Littler, WA; Smith, SA1
Naden, RP; Redman, CW1
Durando, C; Gessa, M; Leidi, L; Maina, G; Margaria, E; Medaglia, M1
Akashi, A; Hashimoto, H; Kanda, A; Tanaka, M1
Bompart, F; Graham, BR; Liu, JB; Prichard, BN; Tomlinson, B1
Ferguson, RK; Vlasses, PH1
Vidt, DG1
Gertel, M; Shapira, Y1
Amon, E; Gonzalez, AR; Mabie, WC; Sibai, BM1
Ashe, RG; Moodley, J; Philpott, RH; Richards, AM1
Burris, JF1
Booth, RJ; Bullock, JY; Wilson, JD1
Riley, AJ1
Prichard, BN; Richards, DA1
Almazov, VA; Bondarenko, BB; Shabrov, AV1
Lubbe, WF1
Prichard, BN1
Latham, L; Lorimer, AR; McAreavey, D; McLaren, AD; Ramsey, LE; Reid, JL; Robertson, JI; Robertson, MP; Weir, RJ1
Calder, AA; Greer, I; Walker, JJ1
Chalmers, JP; Graham, JR; Grygiel, JJ; Mulligan, J; Walkley, J; West, MJ; Wing, LM1
Corvol, P; Lardoux, MD; Thibonnier, M1
Donker, AJ; May, JF; ten Berge, BS; van der Veur, E; Wesseling, H1
Davey, DA; Dommisse, J; Garden, A1
Colombo, G; Fea, F; Foti, F; Pelliccioli, I; Planca, E; Salvioli, G1
Dage, RC; Hsieh, CP1
Broughton Pipkin, F; Lamming, GD; Symonds, EM1
Abassi, ZA; Cuda, G; Golomb, E; Keiser, HR; Panchal, VR; Stylianou, M; Trachewsky, D1
Connelly, JF; Zigmont, EA1
Belfrage, P; Faxelius, G; Hjertberg, R1
Arner, P; Galitzky, J; Lafontan, M; Nordenström, J1
Faxelius, G; Hjertberg, R; Lagercrantz, H1
Abdelwahab, W; Frishman, W; Landau, A1
al-Qattan, F; Makhseed, M; Omu, AE1
Bull, SB; Koren, G; Logan, A; Magee, LA1
Hussein, M; Mooij, JM; Roujouleh, H1
Bogaru, A; Cachat, F; Guignard, JP; Lepori, D; Micheli, JL1
Dennedy, MC; Houlihan, DD; Morrison, JJ; Ravikumar, N1
Heazell, AE; Mahomoud, S; Pirie, AM1
Hamilton, R; Lim, K; Prasad, GV; Vincent, L1
de Jaramillo, IA; López, JC; Pinzón, J; Ruiz, E; Vega-Maleck, JC; Vigil-De Gracia, P1
Al-Harmi, J; Al-Ragum, NS; Mlechkova, L; Omu, AE; Sayed, AF; Vedi, HL1
Abbott, J; Bakes, K; Withers, E; Yancey, LM1
Marik, PE; Varon, J1
Erickson, S; Weder, AB1
Baggio, MR; Berezowski, AT; Calderon, AC; Cavalli, RC; Duarte, G; Marcolin, AC; Martins, WP1
Gong, SP; Huang, LP; Liu, QQ; Yu, YH1
Abudiab, MM; Odunukan, OW; Sinak, LJ1
Alexander, JM; Wilson, KL1
Arulkumaran, N; Lightstone, L1
Buck, BH; Butcher, KS; Choi, V; Coutts, SB; Demchuk, AM; Dowlatshahi, D; Emery, DJ; Gould, BE; Hansen, MB; Hill, MD; Kate, MP; McCourt, R; Mouridsen, K; Østergaard, L1
Charlton, F; Hennessy, A; Makris, A; Xu, B1
Firoz, T; Gordon, R; MacDonell, K; Magee, LA; Payne, BA; Vidler, M; von Dadelszen, P1
Gangooly, S; Jauniaux, E; Muttukrishna, S1
Simon, M; Vadhera, RB1
Anderson, B; Bautista, L; Bofill, J; Darby, M; Kiprono, L; Martin, JN; Morris, R; Novotny, S; Sawardecker, S; Sunesara, I1
Cortes, J; Hall, AB; McKay, C1
Olson-Chen, C; Seligman, NS1
Abreo, A; Greene, N; Kilpatrick, SJ; Main, EK; Melsop, K; Peterson, N; Shields, LE1
Aghajanian, P; Greene, N; Kilpatrick, SJ; Rodriguez, M; Sharma, KJ1
Chawla, N; Kim, RK; Legler, A1
Bobek, G; Hennessy, A; Makris, A; Xu, B1
Barton, JR; Sibai, BM1
Kilpatrick, SJ; Sharma, KJ1
Amaral, LM; LaMarca, B; Owens, M; Wallace, K1
Gaynor, MF; Vondracek, S; Wright, GC1
Flynn, JT; Starr, MC1
Broscious, R; Devabhakthuni, S; Noel, ZR; Watson, K1
Sequeira, RP; Sridharan, K1
Dierkhising, RA; Kuper, PJ; Mara, KC; Poyant, JO; Rabinstein, AA; Ritchie, BM; Wijdicks, EFM1
Chams, N; Gjeka, R; Kumar, S; Peterson, D; Ross, I; Salman, A; Salman, J; Tegeltija, V1
Carrera, JF; Chiota-McCollum, NA; Sorace, BJ; Southerland, AM; Worrall, BB1
Akerman, MB; Elsayad, A; Halpern, TA; Heiselman, CJ; Heo, HJ; Kantorowska, A; Muscat, JC; Sicuranza, GB; Vintzileos, AM1
Chera-Aree, P; Leetheeragul, J; Sampaojarean, U; Surasereewong, S; Tengtrakulcharoen, P; Wataganara, T1
Cawoski, JR; Covvey, JR; DeBiasio, KA; Donnachie, SW; Guarascio, AJ; Montepara, CA; Nemecek, BD; Timanus, EA; Zimmerman, DE1
Cheng, Y; Jiang, YF; Li, JB; Wu, HZ; Yu, D; Zhu, ZN1
Behymer, TP; Bettin, M; Christianson, T; Coleman, ER; Divani, A; Flaherty, ML; Gilkerson, LA; James, ML; King, NKK; Krishnamoorthy, V; Langefeld, CD; McCauley, JL; Ng, Y; Qi, W; Shah, S; Testai, FD; Walsh, KB; Woo, D1
Bako, B; Dawha, YM; Muhammad, S; Usman, H; Yahya, A; Yekeen, A1
Greene, NH; Kilpatrick, SJ; Pon, FF1
Hoffman, MC; Wautlet, CK1
Cho, I; Choe, KR; Jeong, DE; Kim, HJ; Kim, MK; Lee, KN; Park, JY1
Hamidy, Y; Novri, DA; S, D; Savira, M1
Husain, S; Hussain, R; Kausar, M1

Reviews

30 review(s) available for hydralazine and labetalol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Antihypertensive drugs: clinical pharmacology and therapeutic use.
    Drugs, 1977, Volume: 14, Issue:6

    Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clonidine; Diazoxide; Diuretics; Ganglionic Blockers; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Minoxidil; Monoamine Oxidase Inhibitors; Nitroprusside; Potassium; Prazosin; Secologanin Tryptamine Alkaloids; Sympatholytics

1977
Fatal hepatotoxicity induced by hydralazine or labetalol.
    Pharmacotherapy, 1991, Volume: 11, Issue:5

    Topics: Aged; Chemical and Drug Induced Liver Injury; Humans; Hydralazine; Hypertension; Labetalol; Male

1991
Management of hypertensive emergencies: changing therapeutic options.
    American heart journal, 1991, Volume: 122, Issue:1 Pt 2

    Topics: Emergencies; Humans; Hydralazine; Hypertension; Labetalol; Nicardipine; Nitroprusside

1991
Antihypertensive agents--the race for third place.
    Journal of clinical and hospital pharmacy, 1985, Volume: 10, Issue:2

    Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Diazoxide; Felodipine; Humans; Hydralazine; Indoramin; Labetalol; Minoxidil; Nicardipine; Nifedipine; Vasodilator Agents; Verapamil

1985
Antihypertensive drugs in pregnancy.
    Clinics in perinatology, 1985, Volume: 12, Issue:3

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Diazoxide; Diuretics; Female; Fetus; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Nifedipine; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Regional Blood Flow; Uterus

1985
Hypertensive emergencies and urgencies.
    JAMA, 1986, Mar-28, Volume: 255, Issue:12

    Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Clonidine; Diazoxide; Emergencies; Humans; Hydralazine; Hypertension; Hypertension, Malignant; Labetalol; Nitroglycerin; Nitroprusside; Risk; Trimethaphan

1986
[New drugs for deliberate hypotension in anesthesia].
    Harefuah, 1988, Jan-15, Volume: 114, Issue:2

    Topics: Anesthesia; Animals; Humans; Hydralazine; Hypotension, Controlled; Isoflurane; Labetalol

1988
Comparison of labetalol with other anti-hypertensive drugs.
    British journal of clinical pharmacology, 1982, Volume: 13, Issue:1 Suppl

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Diuretics; Drug Therapy, Combination; Ethanolamines; Hemodynamics; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa

1982
[Mechanism of development and principles of treatment of malignant arterial hypertension].
    Klinicheskaia meditsina, 1983, Volume: 61, Issue:11

    Topics: Adrenergic beta-Antagonists; Anemia, Hemolytic; Animals; Antihypertensive Agents; Cyclic AMP; Factor XII; Humans; Hydralazine; Hypertension, Malignant; Labetalol; Platelet Aggregation; Prostaglandins F; Rabbits; Rats; Renin-Angiotensin System; Thromboplastin; Vasopressins; Water-Electrolyte Imbalance

1983
Hypertension in pregnancy. Pathophysiology and management.
    Drugs, 1984, Volume: 28, Issue:2

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Calcium Channel Blockers; Captopril; Clonidine; Diazoxide; Diuretics; Drug Therapy, Combination; Female; Fetal Diseases; Hemodynamics; Humans; Hydralazine; Hypertension; Hypnotics and Sedatives; Labetalol; Magnesium Sulfate; Pregnancy; Pregnancy Complications, Cardiovascular; Reserpine; Sympatholytics; Tranquilizing Agents

1984
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Drugs, 1984, Volume: 28 Suppl 2

    Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia; Antihypertensive Agents; Asthma; Blood Pressure; Clonidine; Diuretics; Drug Therapy, Combination; Ethanolamines; Female; Heart Failure; Humans; Hydralazine; Hypertension; Hypertension, Renal; Infusions, Parenteral; Kidney Failure, Chronic; Labetalol; Methyldopa; Parasympathetic Nervous System; Pheochromocytoma; Pregnancy; Pregnancy Complications, Cardiovascular; Substance Withdrawal Syndrome; Tetanus

1984
Hypertensive crisis.
    Cardiology clinics, 1984, Volume: 2, Issue:2

    Topics: Antihypertensive Agents; Brain Diseases; Cerebrovascular Disorders; Clonidine; Coronary Disease; Diazoxide; Eclampsia; Emergencies; Female; Humans; Hydralazine; Hypertension; Hypertension, Malignant; Labetalol; Minoxidil; Nifedipine; Nitroprusside; Phentolamine; Prazosin; Pregnancy; Pulmonary Edema; Trimethaphan

1984
Management of hypertensive urgencies and emergencies.
    Journal of clinical pharmacology, 1995, Volume: 35, Issue:8

    Topics: Administration, Oral; Antihypertensive Agents; Emergencies; Enalaprilat; Female; Humans; Hydralazine; Hypertension; Infusions, Parenteral; Labetalol; Nicardipine; Nitroglycerin; Nitroprusside

1995
The generalizability of trial data; a comparison of beta-blocker trial participants with a prospective cohort of women taking beta-blockers in pregnancy.
    European journal of obstetrics, gynecology, and reproductive biology, 2001, Volume: 94, Issue:2

    Topics: Adrenergic beta-Antagonists; Adult; Cohort Studies; Databases as Topic; Diabetes, Gestational; Female; Gestational Age; Humans; Hydralazine; Hypertension; Infant, Newborn; Labetalol; Pregnancy; Pregnancy Complications; Pregnancy Complications, Cardiovascular; Prospective Studies; Racial Groups; Randomized Controlled Trials as Topic; Treatment Outcome

2001
Perioperative hypertension management.
    Vascular health and risk management, 2008, Volume: 4, Issue:3

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Enalaprilat; Fenoldopam; Hemodynamics; Humans; Hydralazine; Hypertension; Incidence; Labetalol; Nicardipine; Nitroglycerin; Nitroprusside; Perioperative Care; Postoperative Complications; Propanolamines; Pyridines; Surgical Procedures, Operative; Vascular Resistance; Vasodilator Agents

2008
[Clinical efficacy and perinatal outcome of nifedipine for severe preeclampsia: meta-analysis].
    Zhonghua fu chan ke za zhi, 2012, Volume: 47, Issue:8

    Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension; Infant, Newborn; Labetalol; Nifedipine; Perinatal Mortality; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Respiratory Distress Syndrome, Newborn; Severity of Illness Index

2012
Hypertensive emergencies of pregnancy.
    Obstetrics and gynecology clinics of North America, 2013, Volume: 40, Issue:1

    Topics: Antihypertensive Agents; Calcium Channel Blockers; Creatine; Diuretics; Emergency Medicine; Female; Fetal Monitoring; Humans; Hydralazine; Infusions, Intravenous; Labetalol; Methyldopa; Nifedipine; Nitroprusside; North America; Oliguria; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Proteinuria

2013
Severe pre-eclampsia and hypertensive crises.
    Best practice & research. Clinical obstetrics & gynaecology, 2013, Volume: 27, Issue:6

    Topics: Administration, Intravenous; Administration, Oral; Antihypertensive Agents; Critical Care; Early Diagnosis; Eclampsia; Female; HELLP Syndrome; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Labetalol; Magnesium Sulfate; Methyldopa; Nifedipine; Nitroglycerin; Pre-Eclampsia; Pregnancy; Risk Assessment; Risk Factors; Severity of Illness Index; Treatment Outcome; United Kingdom

2013
Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review.
    BJOG : an international journal of obstetrics and gynaecology, 2014, Volume: 121, Issue:10

    Topics: Administration, Oral; Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Labetalol; Methyldopa; Nifedipine; Postpartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Randomized Controlled Trials as Topic; Treatment Outcome; Vasodilator Agents

2014
Hypertensive emergencies in pregnancy.
    Clinical obstetrics and gynecology, 2014, Volume: 57, Issue:4

    Topics: Antihypertensive Agents; Eclampsia; Emergencies; Female; Humans; Hydralazine; Hypertension; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Severity of Illness Index

2014
Hypertensive Emergencies in Pregnancy.
    Critical care clinics, 2016, Volume: 32, Issue:1

    Topics: Antihypertensive Agents; Cesarean Section; Chronic Disease; Congenital Abnormalities; Emergencies; Esophageal Atresia; Female; Heart Defects, Congenital; Humans; Hydralazine; Hypertension; Hypertension, Pregnancy-Induced; Hypospadias; Labetalol; Labor, Induced; Male; Nifedipine; Postnatal Care; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Prevalence; United States

2016
Postpartum Hypertension: Etiology, Diagnosis, and Management.
    Obstetrical & gynecological survey, 2017, Volume: 72, Issue:4

    Topics: Antihypertensive Agents; Blood Pressure; Disease Management; Female; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Postpartum Period; Pregnancy; Puerperal Disorders

2017
Pathophysiology and Current Clinical Management of Preeclampsia.
    Current hypertension reports, 2017, Volume: 19, Issue:8

    Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Delivery, Obstetric; Endothelium, Vascular; Female; Humans; Hydralazine; Infant, Low Birth Weight; Infant, Newborn; Inflammation; Ischemia; Labetalol; Magnesium Sulfate; Placenta; Pre-Eclampsia; Pregnancy; Premature Birth

2017
Neonatal hypertension: cases, causes, and clinical approach.
    Pediatric nephrology (Berlin, Germany), 2019, Volume: 34, Issue:5

    Topics: Administration, Intravenous; Antihypertensive Agents; Birth Weight; Blood Pressure; Blood Pressure Determination; Clinical Decision-Making; Gestational Age; Humans; Hydralazine; Hypertension; Incidence; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Intensive Care Units, Neonatal; Kidney; Labetalol; Neuroblastoma; Reference Values; Renal Artery Obstruction; Severity of Illness Index; Treatment Outcome

2019
Focused Update on Pharmacologic Management of Hypertensive Emergencies.
    Current hypertension reports, 2018, 06-08, Volume: 20, Issue:7

    Topics: Administration, Oral; Antihypertensive Agents; Blood Pressure; Brain Ischemia; Emergencies; Enalaprilat; Female; Guideline Adherence; Heart Failure; Humans; Hydralazine; Hypertension; Infusions, Intravenous; Intracranial Hemorrhages; Labetalol; Nifedipine; Pre-Eclampsia; Pregnancy; Pyridines; Stroke

2018
Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials.
    British journal of clinical pharmacology, 2018, Volume: 84, Issue:9

    Topics: Antihypertensive Agents; Dose-Response Relationship, Drug; Female; Headache; Humans; Hydralazine; Hypertension; Hypotension; Incidence; Labetalol; Network Meta-Analysis; Nifedipine; Perinatal Death; Pregnancy; Pregnancy Complications, Cardiovascular; Randomized Controlled Trials as Topic; Stillbirth; Tachycardia; Treatment Outcome

2018
Safety and efficacy of intravenous hydralazine and labetalol for the treatment of asymptomatic hypertension in hospitalised patients: A systematic review.
    International journal of clinical practice, 2021, Volume: 75, Issue:7

    Topics: Administration, Intravenous; Antihypertensive Agents; Humans; Hydralazine; Hypertension; Labetalol

2021
Different dosage regimens of nifedipine, labetalol, and hydralazine for the treatment of severe hypertension during pregnancy: a network meta-analysis of randomized controlled trials.
    Hypertension in pregnancy, 2022, Volume: 41, Issue:2

    Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension; Hypertension, Pregnancy-Induced; Infant, Newborn; Labetalol; Network Meta-Analysis; Nifedipine; Pregnancy; Randomized Controlled Trials as Topic

2022
Hypertensive Crisis in Pregnancy.
    Obstetrics and gynecology clinics of North America, 2022, Volume: 49, Issue:3

    Topics: Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension; Labetalol; Nifedipine; Pregnancy

2022

Trials

26 trial(s) available for hydralazine and labetalol

ArticleYear
Labetalol compared with prindolol plus hydraliazine in the treatment of hypertension: a double-blind cross-over study.
    The Medical journal of Australia, 1978, Jan-28, Volume: 1, Issue:2

    Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hydralazine; Hypertension; Labetalol; Male; Middle Aged; Patient Compliance; Pindolol

1978
Antihypertensive effect and plasma levels of labetalol. A comparison with propranolol and dihydrallazine.
    International journal of clinical pharmacology and biopharmacy, 1979, Volume: 17, Issue:2

    Topics: Adult; Dihydralazine; Drug Therapy, Combination; Ethanolamines; Female; Heart Rate; Humans; Hydralazine; Hypertension; Labetalol; Male; Middle Aged; Placebos; Propranolol; Time Factors

1979
Some haemodynamic effects of compound AH 5158 compared with propranolol, propranolol plus hydrallazine, and diazoxide: the use of AH 5158 in the treatment of hypertension.
    Clinical science and molecular medicine. Supplement, 1975, Volume: 2

    Topics: Blood Pressure; Cardiac Output; Clinical Trials as Topic; Diazoxide; Drug Therapy, Combination; Ethanolamines; Heart Rate; Humans; Hydralazine; Hypertension; Labetalol; Physical Exertion; Posture; Propranolol

1975
Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol.
    British journal of obstetrics and gynaecology, 1991, Volume: 98, Issue:5

    Topics: Adult; Blood Flow Velocity; Blood Pressure; Female; Heart Rate; Heart Rate, Fetal; Hemodynamics; Humans; Hydralazine; Hypertension; Infusions, Intravenous; Labetalol; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Cardiovascular; Pulsatile Flow; Random Allocation; Umbilical Arteries

1991
Comparative hemodynamic effects of labetalol and hydralazine in the treatment of postoperative hypertension.
    Journal of clinical anesthesia, 1989, Volume: 1, Issue:3

    Topics: Aged; Female; Hemodynamics; Humans; Hydralazine; Hypertension; Labetalol; Male; Middle Aged; Postoperative Complications; Tachycardia

1989
Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
    Drugs, 1988, Volume: 36 Suppl 6

    Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Cold Temperature; Double-Blind Method; Exercise; Heart Rate; Hemodynamics; Humans; Hydralazine; Isoproterenol; Labetalol; Male; Middle Aged; Phenylephrine; Posture; Propanolamines; Propranolol; Vasodilator Agents

1988
A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy.
    Obstetrics and gynecology, 1987, Volume: 70, Issue:3 Pt 1

    Topics: Adult; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Hydralazine; Hypertension; Labetalol; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Random Allocation

1987
Comparison of labetalol and dihydralazine in hypertensive emergencies of pregnancy.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1987, Mar-21, Volume: 71, Issue:6

    Topics: Blood Pressure; Clinical Trials as Topic; Dihydralazine; Female; Heart Rate; Heart Rate, Fetal; Humans; Hydralazine; Hypertension; Labetalol; Platelet Count; Pregnancy; Pregnancy Complications, Cardiovascular; Random Allocation; Time Factors

1987
Antinuclear antibodies in patients on acebutolol.
    British journal of clinical pharmacology, 1980, Volume: 9, Issue:5

    Topics: Adrenergic Agonists; Blood Glucose; Blood Pressure; Clinical Trials as Topic; Ethanolamines; Humans; Hydralazine; Labetalol; Male; Phentolamine; Placebos

1980
Some further evidence for partial agonist activity of labetalol.
    British journal of clinical pharmacology, 1980, Volume: 9, Issue:5

    Topics: Adrenergic Agonists; Blood Glucose; Blood Pressure; Clinical Trials as Topic; Ethanolamines; Humans; Hydralazine; Labetalol; Male; Phentolamine; Placebos

1980
"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.
    British medical journal (Clinical research ed.), 1984, Jan-14, Volume: 288, Issue:6411

    Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Labetalol; Male; Methyldopa; Middle Aged; Minoxidil; Prazosin

1984
Treatment of acute pregnancy-related hypertension: labetalol and hydralazine compared.
    Postgraduate medical journal, 1983, Volume: 59 Suppl 3

    Topics: Ethanolamines; Female; Heart Rate; Humans; Hydralazine; Hypertension; Labetalol; Pregnancy; Pregnancy Complications, Cardiovascular

1983
Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
    The Medical journal of Australia, 1980, Mar-08, Volume: 1, Issue:5

    Topics: Antihypertensive Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethanolamines; Female; Heart Rate; Humans; Hydralazine; Hypertension; Labetalol; Male; Middle Aged; Placebos; Propranolol

1980
Comparative trial of labetalol and acebutolol, alone or associated with dihydralazine, in treatment of essential hypertension.
    British journal of clinical pharmacology, 1980, Volume: 9, Issue:6

    Topics: Acebutolol; Adult; Clinical Trials as Topic; Dihydralazine; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hydralazine; Hypertension; Labetalol; Male; Middle Aged; Renin

1980
Comparison of labetalol, propranolol and hydralazine in hypertensive out-patients.
    European journal of clinical pharmacology, 1982, Volume: 21, Issue:6

    Topics: Adult; Clinical Trials as Topic; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hydralazine; Hypertension; Labetalol; Male; Middle Aged; Propranolol; Time Factors

1982
Intravenous labetalol and intravenous dihydralazine in severe hypertension in pregnancy.
    Clinical and experimental hypertension. Part B, Hypertension in pregnancy, 1982, Volume: 1, Issue:2-3

    Topics: Adult; Blood Pressure; Dihydralazine; Eclampsia; Ethanolamines; Female; Fetus; Humans; Hydralazine; Infant, Newborn; Infusions, Parenteral; Labetalol; Pre-Eclampsia; Pregnancy; Random Allocation

1982
Comparison of the alpha and beta blocking drug, labetalol, and methyl dopa in the treatment of moderate and severe pregnancy-induced hypertension.
    Clinical and experimental hypertension, 1980, Volume: 2, Issue:5

    Topics: Adult; Blood Pressure; Creatinine; Ethanolamines; Female; Fetus; Humans; Hydralazine; Hypertension; Labetalol; Labor, Obstetric; Metabolic Clearance Rate; Methyldopa; Potassium; Pregnancy; Pregnancy Complications, Cardiovascular; Sodium; Uric Acid

1980
Comparison of outcome of labetalol or hydralazine therapy during hypertension in pregnancy in very low birth weight infants.
    Acta obstetricia et gynecologica Scandinavica, 1993, Volume: 72, Issue:8

    Topics: Adult; Female; Humans; Hydralazine; Infant, Low Birth Weight; Infant, Newborn; Labetalol; Pre-Eclampsia; Pregnancy; Pregnancy Outcome

1993
Effect of antihypertensive therapy in preeclampsia on levels of serum interleukin-4.
    Gynecologic and obstetric investigation, 1996, Volume: 42, Issue:4

    Topics: Adult; Antihypertensive Agents; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydralazine; Infusions, Intravenous; Interleukin-4; Labetalol; Methyldopa; Pre-Eclampsia; Pregnancy

1996
Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial.
    Hypertension in pregnancy, 2007, Volume: 26, Issue:2

    Topics: Adult; Analysis of Variance; Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Infusions, Intravenous; Labetalol; Panama; Postpartum Period; Research Design; Severity of Illness Index; Treatment Outcome

2007
Changes in fetal and maternal Doppler parameters observed during acute severe hypertension treatment with hydralazine or labetalol: a randomized controlled trial.
    Ultrasound in medicine & biology, 2011, Volume: 37, Issue:1

    Topics: Acute Disease; Adult; Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension; Labetalol; Middle Cerebral Artery; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Statistics, Nonparametric; Treatment Outcome; Ultrasonography, Doppler; Ultrasonography, Prenatal; Umbilicus

2011
Blood pressure reduction does not reduce perihematoma oxygenation: a CT perfusion study.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2014, Volume: 34, Issue:1

    Topics: Aged; Antihypertensive Agents; Blood Pressure; Cerebral Hemorrhage; Female; Hematoma; Humans; Hydralazine; Labetalol; Male; Oxygen Consumption; Tomography, X-Ray Computed; Treatment Outcome

2014
Impedance cardiography assessed treatment of acute severe pregnancy hypertension: a randomized trial.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2016, Volume: 29, Issue:2

    Topics: Adult; Antihypertensive Agents; Blood Pressure; Cardiac Output; Cardiography, Impedance; Female; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Infant, Newborn; Labetalol; Pilot Projects; Pregnancy; Prospective Studies; Vascular Resistance; Young Adult

2016
Initial antihypertensive agent effects on acute blood pressure after intracerebral haemorrhage.
    Stroke and vascular neurology, 2022, Volume: 7, Issue:5

    Topics: Antihypertensive Agents; Blood Pressure; Cerebral Hemorrhage; Humans; Hydralazine; Hypertension; Labetalol; Nicardipine

2022
Comparison of intravenous labetalol and hydralazine for severe hypertension in pregnancy in Northeastern Nigeria: A randomized controlled trial.
    Pregnancy hypertension, 2022, Volume: 29

    Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension; Infant; Infant, Newborn; Labetalol; Nigeria; Perinatal Death; Pre-Eclampsia; Pregnancy

2022
Effectiveness of nifedipine, labetalol, and hydralazine as emergency antihypertension in severe preeclampsia: a randomized control trial.
    F1000Research, 2022, Volume: 11

    Topics: Antihypertensive Agents; Female; Humans; Hydralazine; Labetalol; Nifedipine; Pre-Eclampsia; Pregnancy

2022

Other Studies

53 other study(ies) available for hydralazine and labetalol

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Labetalol in the treatment of hypertensive renal patients.
    The Medical journal of Australia, 1978, Feb-25, Volume: 1, Issue:4

    Topics: Adrenergic beta-Antagonists; Adult; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hydralazine; Hypertension; Kidney Failure, Chronic; Labetalol; Male; Middle Aged; Minoxidil; Time Factors

1978
Treatment of severe and resistant hypertension.
    British journal of hospital medicine, 1978, Volume: 20, Issue:4

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Clonidine; Diazoxide; Diet, Sodium-Restricted; Diuretics; Humans; Hydralazine; Hypertension; Injections, Intravenous; Labetalol; Methyldopa; Nitroprusside; Patient Dropouts; Trimethaphan; Vasodilator Agents

1978
Management of hypertensive emergencies.
    Archives of disease in childhood, 1992, Volume: 67, Issue:9

    Topics: Adolescent; Child; Child, Preschool; Diazoxide; Emergencies; Female; Humans; Hydralazine; Hypertension; Infant; Infusions, Intravenous; Injections, Intramuscular; Labetalol; Male; Nitroprusside

1992
Intravenously administered labetalol for treatment of hypertension in children.
    The Journal of pediatrics, 1992, Volume: 120, Issue:1

    Topics: Adolescent; Child; Child, Preschool; Creatinine; Diazoxide; Heart Rate; Humans; Hydralazine; Hypertension; Infusions, Intravenous; Labetalol; Nifedipine; Nitroprusside; Potassium; Time Factors

1992
Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol.
    British journal of obstetrics and gynaecology, 1991, Volume: 98, Issue:11

    Topics: Female; Heart Rate, Fetal; Hemodynamics; Humans; Hydralazine; Hypertension; Labetalol; Pregnancy; Pregnancy Complications, Cardiovascular

1991
Effects of vasodilators on isolated human uteroplacental arteries.
    Obstetrics and gynecology, 1991, Volume: 77, Issue:5

    Topics: Angiotensin II; Arteries; Chorionic Villi; Dinoprost; Female; Humans; Hydralazine; Labetalol; Nitrendipine; Norepinephrine; Potassium; Prazosin; Pregnancy; Uterus; Vasoconstriction; Vasodilator Agents; Vasopressins

1991
Role of the alpha-adrenergic blocking effect in the acute hypotensive effect of beta-adrenergic blocking drugs with alpha-blocking activities in conscious SHR.
    Japanese journal of pharmacology, 1985, Volume: 39, Issue:4

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Heart Rate; Hydralazine; Labetalol; Male; Prazosin; Propanolamines; Rats; Rats, Inbred SHR; Time Factors

1985
[Hypertension in pregnancy: proposed monitoring and therapy].
    Minerva ginecologica, 1985, Volume: 37, Issue:10

    Topics: Adrenergic beta-Antagonists; Captopril; Diuretics; Female; Follow-Up Studies; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Prazosin; Pregnancy; Pregnancy Complications, Cardiovascular

1985
Analysis of the mechanism underlying the vasodilator action of carvedilol in pithed spontaneously hypertensive rats.
    Drugs, 1988, Volume: 36 Suppl 6

    Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Carbazoles; Carvedilol; Decerebrate State; Dose-Response Relationship, Drug; Drug Interactions; Hydralazine; Hypertension; Labetalol; Prazosin; Propanolamines; Rats; Rats, Inbred SHR; Vasodilator Agents

1988
Current concepts in treatment of hypertensive emergencies.
    American heart journal, 1986, Volume: 111, Issue:1

    Topics: Diazoxide; Drug Therapy, Combination; Emergencies; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Nitroglycerin; Nitroprusside; Phentolamine; Reserpine; Sympathomimetics; Trimethaphan; Vasodilator Agents

1986
Drugs for hypertensive emergencies.
    The Medical letter on drugs and therapeutics, 1985, Mar-01, Volume: 27, Issue:682

    Topics: Administration, Oral; Captopril; Clonidine; Diazoxide; Emergencies; Humans; Hydralazine; Hypertension; Infusions, Parenteral; Labetalol; Nifedipine; Nitroprusside; Trimethaphan

1985
Hypertensive emergencies.
    American family physician, 1985, Volume: 32, Issue:1

    Topics: Antihypertensive Agents; Blood Pressure; Clonidine; Diazoxide; Emergencies; Humans; Hydralazine; Hypertension; Hypertension, Malignant; Labetalol; Nitroprusside; Propranolol; Risk; Trimethaphan

1985
[Effectiveness of antihypertensive treatment with labetalol as compared with the combination of hydralazine and propranolol].
    Bollettino della Societa italiana di cardiologia, 1981, Volume: 26, Issue:12

    Topics: Adult; Drug Evaluation; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hydralazine; Hypertension; Labetalol; Male; Middle Aged; Propranolol

1981
Direct vasodilatation by labetalol in anaesthetized dogs.
    British journal of pharmacology, 1980, Volume: 70, Issue:2

    Topics: Adrenalectomy; Anesthesia; Animals; Clonidine; Diazoxide; Dogs; Ethanolamines; Female; Hemodynamics; Hydralazine; Labetalol; Male; Vagotomy; Vasodilator Agents

1980
Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats.
    The American journal of physiology, 1994, Volume: 267, Issue:4 Pt 2

    Topics: Actins; Angiotensin II; Animals; Base Sequence; Biphenyl Compounds; Blood Pressure; Captopril; Cardiomegaly; DNA; DNA Primers; Dose-Response Relationship, Drug; Gene Expression; Genes, fos; Heart; Hydralazine; Hydroxyproline; Imidazoles; Isoproterenol; Labetalol; Losartan; Male; Methyldopa; Molecular Sequence Data; Myocardium; Myosins; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA; RNA, Messenger; Tetrazoles; Transcription, Genetic

1994
Intravenous antihypertensive agents for patients unable to take oral medications.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1995, Jul-15, Volume: 52, Issue:14

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Calcium Channel Blockers; Enalaprilat; Furosemide; Humans; Hydralazine; Hypertension; Injections, Intravenous; Labetalol; Methyldopa; Nitroglycerin; Nitroprusside; Vasodilator Agents

1995
Role of vascular alpha-2 adrenoceptors in regulating lipid mobilization from human adipose tissue.
    The Journal of clinical investigation, 1993, Volume: 91, Issue:5

    Topics: Adipose Tissue; Adult; Analysis of Variance; Clonidine; Dose-Response Relationship, Drug; Epinephrine; Ethanol; Female; Glycerol; Humans; Hydralazine; Kinetics; Labetalol; Lipid Mobilization; Male; Nitroprusside; Propranolol; Receptors, Adrenergic, alpha; Time Factors; Yohimbine

1993
Neonatal adaptation in hypertensive pregnancy--a study of labetalol vs hydralazine treatment.
    Journal of perinatal medicine, 1993, Volume: 21, Issue:1

    Topics: Adolescent; Adult; Female; Fetal Hypoxia; Hemodynamics; Humans; Hydralazine; Infant, Newborn; Labetalol; Maternal-Fetal Exchange; Pre-Eclampsia; Pregnancy; Sweden

1993
Factor analysis, including antihypertensive medication, of the outcome of pregnancy in pregnancy-associated hypertension.
    Kidney & blood pressure research, 2001, Volume: 24, Issue:2

    Topics: Antihypertensive Agents; Apgar Score; Cesarean Section; Comorbidity; Disease Susceptibility; Female; Fetal Death; Humans; Hydralazine; Hypertension; Infant, Newborn; Labetalol; Multivariate Analysis; Nifedipine; Parity; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy in Diabetics; Pregnancy Outcome; Retrospective Studies; Risk Factors

2001
Severe hypertension and massive proteinuria in a newborn with renal artery stenosis.
    Pediatric nephrology (Berlin, Germany), 2004, Volume: 19, Issue:5

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aorta, Abdominal; Blood Pressure; Captopril; Diuretics; Female; Furosemide; Humans; Hydralazine; Hypertension, Renovascular; Infant, Newborn; Labetalol; Magnetic Resonance Imaging; Nitroprusside; Proteinuria; Radiography; Renal Artery Obstruction

2004
Anti-hypertensive therapy and the feto-placental circulation: effects on umbilical artery resistance.
    Journal of perinatal medicine, 2004, Volume: 32, Issue:4

    Topics: Adult; Antihypertensive Agents; Dose-Response Relationship, Drug; Female; Fetus; Humans; Hydralazine; Labetalol; Magnesium Sulfate; Methyldopa; Nifedipine; Placenta; Pre-Eclampsia; Pregnancy; Regional Blood Flow; Umbilical Arteries; Vascular Resistance

2004
The treatment of severe hypertension in pregnancy: a review of current practice and knowledge in West-Midlands maternity units.
    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2004, Volume: 24, Issue:8

    Topics: Antihypertensive Agents; Female; Hospital Units; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Obstetrics; Practice Patterns, Physicians'; Pregnancy

2004
Minimal change disease in association with fire coral (Millepora species) exposure.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2006, Volume: 47, Issue:1

    Topics: Acute Kidney Injury; Animals; Anthozoa; Barbados; Bites and Stings; Combined Modality Therapy; Diving; Edema; Female; Forearm Injuries; Furosemide; Humans; Hydralazine; Intubation, Intratracheal; Labetalol; Marine Toxins; Middle Aged; Mitral Valve Insufficiency; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Pulmonary Edema; Ramipril

2006
Magnesium sulphate therapy in women with pre-eclampsia and eclampsia in Kuwait.
    Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2008, Volume: 17, Issue:3

    Topics: Adult; Antihypertensive Agents; Calcium Channel Blockers; Drug Therapy, Combination; Eclampsia; Female; Humans; Hydralazine; Kuwait; Labetalol; Magnesium Sulfate; Pre-Eclampsia; Pregnancy; Prospective Studies; Risk Factors; Tocolytic Agents; Treatment Outcome

2008
Postpartum preeclampsia: emergency department presentation and management.
    The Journal of emergency medicine, 2011, Volume: 40, Issue:4

    Topics: Adolescent; Adult; Anti-Anxiety Agents; Anticonvulsants; Antihypertensive Agents; Benzodiazepines; Eclampsia; Emergency Medicine; Female; Headache; Humans; Hydralazine; Hypertension; Labetalol; Magnesium Sulfate; Postpartum Period; Pre-Eclampsia; Pregnancy; Retrospective Studies; Seizures; Vision Disorders; Young Adult

2011
Treatment of hypertension in the inpatient setting: use of intravenous labetalol and hydralazine.
    Journal of clinical hypertension (Greenwich, Conn.), 2010, Volume: 12, Issue:1

    Topics: Adult; Aged; Antihypertensive Agents; Female; Hospitalization; Humans; Hydralazine; Hypertension; Infusions, Intravenous; Labetalol; Male; Middle Aged; Retrospective Studies; Treatment Outcome

2010
Committee Opinion no. 514: emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia.
    Obstetrics and gynecology, 2011, Volume: 118, Issue:6

    Topics: Algorithms; Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Labetalol; Pregnancy

2011
48-year-old man with cough and leg swelling.
    Mayo Clinic proceedings, 2012, Volume: 87, Issue:12

    Topics: Acute Disease; Antihypertensive Agents; Cerebrovascular Circulation; Cough; Dyspnea; Echocardiography; Edema; Emergencies; Humans; Hydralazine; Hypertension; Labetalol; Lower Extremity; Male; Metoprolol; Middle Aged; Nitroglycerin; Sleep Apnea Syndromes; Vasodilator Agents

2012
Antihypertensive drugs methyldopa, labetalol, hydralazine, and clonidine improve trophoblast interaction with endothelial cellular networks in vitro.
    Journal of hypertension, 2014, Volume: 32, Issue:5

    Topics: Antihypertensive Agents; Cells, Cultured; Clonidine; Coculture Techniques; Culture Media, Conditioned; Cytokines; Endothelium, Vascular; Female; Humans; Hydralazine; In Vitro Techniques; Labetalol; Methyldopa; Trophoblasts

2014
In-vitro study of the effect of anti-hypertensive drugs on placental hormones and angiogenic proteins synthesis in pre-eclampsia.
    PloS one, 2014, Volume: 9, Issue:9

    Topics: Activins; Angiogenic Proteins; Antigens, CD; Antihypertensive Agents; Chorionic Gonadotropin; Chorionic Villi; Dose-Response Relationship, Drug; Endoglin; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydralazine; Labetalol; Methyldopa; Placenta; Placental Hormones; Pravastatin; Pre-Eclampsia; Pregnancy; Receptors, Cell Surface; Time Factors; Tissue Culture Techniques; Vascular Endothelial Growth Factor Receptor-1

2014
Time to Blood Pressure Control Before Thrombolytic Therapy in Patients With Acute Ischemic Stroke: Comparison of Labetalol, Nicardipine, and Hydralazine.
    The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 2015, Volume: 47, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Brain Ischemia; Female; Fibrinolytic Agents; Humans; Hydralazine; Hypertension; Infusions, Intravenous; Labetalol; Male; Middle Aged; Nicardipine; Retrospective Studies; Stroke; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator

2015
Severe maternal morbidity in a large cohort of women with acute severe intrapartum hypertension.
    American journal of obstetrics and gynecology, 2016, Volume: 215, Issue:1

    Topics: Adult; Antihypertensive Agents; California; Female; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Labetalol; Morbidity; Nifedipine; Pregnancy; Retrospective Studies; Young Adult

2016
Risks of parenteral antihypertensive therapy for the treatment of severe maternal hypertension are low.
    Hypertension in pregnancy, 2016, Volume: 35, Issue:1

    Topics: Adult; Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Hypotension; Labetalol; Pre-Eclampsia; Pregnancy; Risk Assessment

2016
Glucagon-induced hypertensive emergency: a case report.
    Journal of clinical anesthesia, 2016, Volume: 35

    Topics: Antihypertensive Agents; Emergencies; Female; Gastrointestinal Agents; Glucagon; Humans; Hydralazine; Hypertension; Labetalol; Middle Aged; Nitroglycerin; Vasodilator Agents

2016
Antihypertensive methyldopa, labetalol, hydralazine, and clonidine reversed tumour necrosis factor-α inhibited endothelial nitric oxide synthase expression in endothelial-trophoblast cellular networks.
    Clinical and experimental pharmacology & physiology, 2017, Volume: 44, Issue:3

    Topics: Antihypertensive Agents; Cells, Cultured; Clonidine; Coculture Techniques; Culture Media, Conditioned; Endothelial Cells; Endothelium, Vascular; Female; Humans; Hydralazine; Interleukin-1 Receptor-Like 1 Protein; Labetalol; Methyldopa; Nitric Oxide Synthase Type III; Trophoblasts; Tumor Necrosis Factor-alpha; Uterus

2017
Controversies Regarding Diagnosis and Treatment of Severe Hypertension in Pregnancy.
    Clinical obstetrics and gynecology, 2017, Volume: 60, Issue:1

    Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension; Labetalol; Pre-Eclampsia; Pregnancy

2017
Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patients.
    Therapeutic advances in cardiovascular disease, 2018, Volume: 12, Issue:1

    Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Adrenergic Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Colorado; Drug Utilization Review; Electronic Health Records; Female; Hospitalization; Hospitals, University; Humans; Hydralazine; Hypertension; Labetalol; Male; Middle Aged; Practice Patterns, Physicians'; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome; Vasodilator Agents

2018
Nicardipine Reduces Blood Pressure Variability After Spontaneous Intracerebral Hemorrhage.
    Neurocritical care, 2019, Volume: 30, Issue:1

    Topics: Administration, Intravenous; Adult; Aged; Antihypertensive Agents; Blood Pressure; Cerebral Hemorrhage; Female; Humans; Hydralazine; Labetalol; Male; Middle Aged; Nicardipine; Retrospective Studies; Treatment Outcome

2019
Improving the use of intravenous antihypertensive medications in the hospital setting: a quality improvement initiative for patient safety.
    BMJ open quality, 2019, Volume: 8, Issue:4

    Topics: Administration, Intravenous; Antihypertensive Agents; Enalapril; Female; Health Personnel; Hospitals; Humans; Hydralazine; Hypertension; Labetalol; Patient Safety; Quality Improvement; Retrospective Studies

2019
Delay to Tissue Plasminogen Activator in Hypertensive Stroke Patients: An Analysis of Delay Duration Across Agents.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2020, Volume: 29, Issue:2

    Topics: Aged; Antihypertensive Agents; Blood Pressure; Drug Administration Schedule; Female; Fibrinolytic Agents; Humans; Hydralazine; Hypertension; Infusions, Intravenous; Labetalol; Male; Nicardipine; Retrospective Studies; Stroke; Thrombolytic Therapy; Time Factors; Time-to-Treatment; Tissue Plasminogen Activator; Treatment Outcome

2020
Identification of factors associated with delayed treatment of obstetric hypertensive emergencies.
    American journal of obstetrics and gynecology, 2020, Volume: 223, Issue:2

    Topics: Administration, Intravenous; Administration, Oral; Adult; After-Hours Care; Antihypertensive Agents; Black or African American; Chronic Disease; Emergencies; Ethnicity; Female; Gestational Age; Hispanic or Latino; Humans; Hydralazine; Hypertension; Hypertension, Pregnancy-Induced; Labetalol; Labor, Obstetric; Nifedipine; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Retrospective Studies; Risk Factors; Severity of Illness Index; Time-to-Treatment; White People

2020
Clinical Experiences of Intravenous Hydralazine and Labetalol for Acute Treatment of Severe Hypertension in Pregnant Thai Women.
    Journal of clinical pharmacology, 2020, Volume: 60, Issue:12

    Topics: Administration, Intravenous; Adult; Antihypertensive Agents; Apgar Score; Asian People; Blood Pressure; Cesarean Section; Female; Heart Rate, Fetal; Humans; Hydralazine; Hypertension; Hypertension, Pregnancy-Induced; Infant, Newborn; Labetalol; Magnesium Sulfate; Pregnancy; Retrospective Studies; Seizures; Treatment Outcome; Young Adult

2020
Race/ethnicity differences in response to acute antihypertensive treatment of peripartum severe hypertension.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2022, Volume: 35, Issue:25

    Topics: Antihypertensive Agents; Blood Pressure; Ethnicity; Female; Humans; Hydralazine; Hypertension; Labetalol; Nifedipine; Peripartum Period; Pregnancy; Retrospective Studies

2022
Use of continuous infusion of nicardipine to control persistent postpartum hypertension: A retrospective study.
    Medicine, 2022, Dec-23, Volume: 101, Issue:51

    Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension; Labetalol; Nicardipine; Postpartum Period; Pregnancy; Retrospective Studies

2022
Comparison of efficacy of intravenous labetalol and intravenous hydralazine for management of pre-eclampsia in pregnant women.
    African health sciences, 2023, Volume: 23, Issue:1

    Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension; Hypotension; Labetalol; Pre-Eclampsia; Pregnancy; Pregnant Women

2023